This customization allows prescribers to adjust concentrations and volumes based on a patient's response, medical history, and metabolic profile
Advise women to inform their healthcare provider if they are pregnant or intend to become pregnant [see Use in SpecificPopulations (8.1, 8.3)]
Make sure to rotate injection sites each week to prevent irritation
Data analysis occurred from March to April 2023, with additional analysis in February 2024
Persistent fatigue warrants evaluation for undereating, sleep deprivation, thyroid dysfunction, or anemianone of which are direct tirzepatide effects
The minimum washout period for genuine effect cessation is 96 hours (four days), not the 48-hour plasma clearance window